November 10, 2003 - DEFA14A: Additional definitive proxy soliciting materials and Rule 14(a)(12) material


		OMB APPROVAL

		OMB Number:		3235-0059
		Expires:		August 31, 2004
		Estimated average burden hours per response		14.73

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )


	Filed by the Registrant x
	Filed by a Party other than the Registrant o

	Check the appropriate box:


	o Preliminary Proxy Statement
	o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
	o Definitive Proxy Statement
	x Definitive Additional Materials
	o Soliciting Material Pursuant to §240.14a-12

eXegenics Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):


	o No fee required.
	o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.


	1) Title of each class of securities to which transaction applies:


	2) Aggregate number of securities to which transaction applies:


	3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):


	4) Proposed maximum aggregate value of transaction:


	5) Total fee paid:


	o Fee paid previously with preliminary materials.


	o Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.


	1) Amount Previously Paid:


	2) Form, Schedule or Registration Statement No.:


	3) Filing Party:


	4) Date Filed:


SEC 1913 (02-02)	Persons who potentially are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

(EXEGENICS INC. LOGO)

FOR IMMEDIATE RELEASE


		Contact:		WaLisa M. Davenport
				*eXegenics* Inc.
				(214) 358-2000

				William Fiske (Information Agent)
				Georgeson Shareholder Communications Inc.
				Banks and Brokers: (212) 440-9800
				All Others Call Toll-Free: (800) 964-0733

FORMER NASDAQ CFO APPOINTED TO EXEGENICS BOARD

Gordon Martin to serve on Audit Committee

DALLAS, November 10, 2003  eXegenics Inc. announced that Gordon Martin, a former Chief Financial Officer of the NASDAQ Stock Market, Inc., has been appointed to the Companys Board of Directors. He will also serve as a member of the Companys Audit Committee.

Mr. Martin, 55, was CFO of the NASDAQ from 2000 to 2001 and served as a Managing Director of CIBC World Markets from 1995 to 2000. Previously he also served in various management positions with Westpac Banking Corporation from 1993 to 1995 and with Marine Midland Bank from 1976 to 1993. A certified public accountant, he began his career with Price Waterhouse after receiving an MBA from SUNY Buffalo and a BS from Canisius College.

Commenting on the appointment, Ronald L. Goode, Ph.D., Chairman and CEO of eXegenics, said, We are extremely fortunate and very pleased to have Gordon Martin join the Board of eXegenics. He will bring to our deliberations a wealth of experience in financial matters, transaction negotiations and corporate governance, and provide the independent oversight so critical to shareholder confidence in todays business environment.

Safe Harbor

This release contains forward-looking statements. The words believe, expect, intend, anticipate, variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. These statements are subject to certain risks, uncertainties and assumptions that are difficult to predict. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. eXegenics undertakes no obligation to update any forward-looking statement to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.